Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis

Inflammatory Bowel Diseases

Volumn 16, Issue 5, 2010, Pages 856-869

  Pasternak, Brad A ^a   D'Mello, Sharon ^b   Jurickova, Ingrid I ^b   Han, Xiaonan ^b   Willson, Tara ^b   Flick, Leah ^b   Petiniot, Lisa ^b   Uozumi, Naonori ^b   Divanovic, Senad ^b   Traurnicht, Anna ^b   Bonkowski, Erin ^b   Kugathasan, Subra ^c   Karp, Christopher L ^b   Denson, Lee A ^b  

^a PHOENIX CHILDREN'S HOSPITAL   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute phase response; Endotoxin; Inflammatory bowel disease; Linear growth

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; ENDOTOXIN ANTIBODY; ENDOTOXIN CORE IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; MERCAPTOPURINE; PREDNISONE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DRUG EXPOSURE; FEMALE; GENE DELETION; GROWTH DISORDER; HUMAN; INFANT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; WEIGHT REDUCTION; WILD TYPE;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; ADOLESCENT; ADULT; ANIMALS; BIOLOGICAL MARKERS; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; CYTOKINES; ENEMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GROWTH DISORDERS; HUMANS; INFANT; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; TOLL-LIKE RECEPTOR 4; TRINITROBENZENESULFONIC ACID; YOUNG ADULT;

EID: 77950666046     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21132     Document Type: Article

References (33)

1. Packey CD, Sartor RB. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med. 2008;263: 597-606.
2. Kim SC, Tonkonogy SL, Albright CA, et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology. 2005;128:891-906.
3. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411:603-606.
4. 4. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM. and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007;39:830-832. (Pubitemid 47014496)
5. Dubinsky MC, Kugathasan S, Mei L, et al. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin Gastroenterol. Hepatol. 2008;6:1105-1111.
6. 6. Hollander D, Vadheim CM, Brettholz E, et al. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med. 1986;105:883-885. (Pubitemid 17201765)
7. Gardiner KR, Halliday MI, Barclay GR, et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut. 1995;36:897-901.
8. Pastor Rojo O, Lopez San Roman A, Albeniz Arbizu E, et al. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:269-277.
9. Wellmann W, Fink PC, Benner F, et al. Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut. 1986;27:814-820.
10. Zweigner J, Schumann. RR, Weber JR. The role of lipopolysaccharidebinding protein in modulating the innate immune response. Microbes Infect. 2006;8:946-952.
11. 11. Currie CG, McCallum K, Poxton IR. Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli. O157 in health and disease. J Med. Microbiol. 2001;50:345-354. (Pubitemid 32239019)
12. Moretti EW, Newman MF, Muhlbaier LH, et al. Effects of decreased preoperative endotoxin core antibody levels on long-term mortality after coronary artery bypass graft surgery. Arch Surg. 2006;141: 637-641; discussion 642.
13. Stephens RC, Fidler K, Wilson P, et al. Endotoxin immunity and the development of the systemic inflammatory response syndrome in critically ill children. Intensive Care Med. 2006;32:286-294.
14. Kronborg G, Fomsgaard A, Galanos C, et al. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients. J Clin Microbiol. 1992;30:1848-1855.
15. 15. Hamilton-Davies C, Barclay GR, Murphy WG, et al. Passive immunisation with IgG endotoxin core antibody hyperimmune fresh frozen plasma. Vox Sang. 1996;71:165-169. (Pubitemid 26341156)
16. Boirivant M, Amendola A, Butera A, et al. A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis. Gastroenterology. 2008;135:1612-1623 e1615.
17. 17. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229-241. (Pubitemid 38962578)
18. Wang X, Jiang J, Warram J, et al. Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity. Mol Endocrinol. 2008;22:1427-1437.
19. 19. Gomariz RP, Arranz A, Abad C, et al. Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP. J Leukoc Biol. 2005;78:491-502. (Pubitemid 41061321)
20. 20. Szebeni B, Veres G, Dezsofi. A, et al. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clin Exp Immunol. 2008;151: 34-41. (Pubitemid 350230984)
21. Fukata M, Michelsen KS, Eri R, et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol. 2005;288:01055-1065.
22. Fukata M, Breglio K, Chen A, et al. The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J Immunol. 2008;180:1886-1894.
23. Griffiths AM, Nguyen P, Smith C, et al. Growth and clinical course of children with Crohn's disease. Gut. 1993;34:939-943.
24. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
25. Neurath MF, Fuss I, Kelsall BL, et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp Med. 1995; 182:1281-1290.
26. Finkelman FD, Morris SC. Development of an assay to measure in vivo cytokine production in the mouse. Int Immunol. 1999; 11: 1811-1818.
27. 27. Browning BL, Huebner C, Petermann I, et al. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol. 2007;102:2504-2512. (Pubitemid 47631777)
28. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1371.
29. DiFedele LM, He J, Bonkowski EL, et al. Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis. Gastroenterology. 2005;128:1278-1291.
30. te Velde AA, de Kort F, Sterrenburg E, et al. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 325-330.
31. Han X, Osuntokun B, Benight N, et al. Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis. Am J Pathol. 2006; 169:1999-2013.
32. te Velde AA, Verstege MI, Hommes DW. Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis. 2006;12:995-999.
33. Berin MC, Zheng Y, Domaradzki M, et al. Role of TLR4 in allergic sensitization to food proteins in mice. Allergy. 2006;61:64-71.